HOME ABOUT FUNDS INVESTORS NEWS CONTACT FUNDS NIK I NIK II NIK III NIK IV NIK VI CrayoNano AS Founded:2012 Sector:MATERIALS/NANO CrayoNano is developing deep UV LEDs based on a patented technology of nanowires grown on graphene where graphene is used as both substrate and transparent electrode. This unique device structure will allow for a much higher efficiency, longer lifetime and lower cost compared to existing technology. This significant improvement will radically enable new applications and improve critical applications such as water and food processing disinfection, air purification and environmental monitoring and life science measurements. ORG.NO:998682525 Website: http://crayonano.com/ Hystorsys (Hydrogen Storage & Systems) AS Founded:2005 Sector:INDUSTY Hystorsys is a provider of patented high purity compressors for hydrogen based on metal hydride (MH) technology. Our compressor have no moving parts and practically no noise and vibrations. Using waste heat, amongst others commonly available from a range of industrial processes, the compressor may be operated at almost no energy cost. The metal hydride compressors have a very low maintenance level, and hence also low maintenance cost. ORG.NO:989001841 Website: http://www.hystorsys.no/ Initial Force AS Founded:2006 Sector:ICT Initial Force provides software that can record and analyse athletic motion, marketed under the Swing Catalyst brand. The products are integrated and allow athletes and instructors to optimise performance through advanced analysis. ORG.NO:990340048 Website: https://www.swingcatalyst.com/ CondAlign AS Founded:2010 Sector:MATERIALS/NANO CondAlign provides a technological solution to align electrically conductive material to restructure the material into film or composite. The process allows retains material characteristics and reduces the need for fillers which reduces costs. The patented technology is well suited for roll-to-roll, a high-speed manufacturing process. ORG.NO:996081001 Website: http://www.condalign.no/ Augmenti AS Founded:2007 Sector:ICT Augmenti provides Augmented Reality (AR) software and hardware for decision support and situational awareness solutions for military use. By using augmented reality techniques, digital symbols giving critical situational information, are displayed on top of the real geographic vision in a shooters sight. Thereby, a complete overview of the battle situation is obtained. The company offers two product lines; ARLA and ARBiN. ARLA is the augmented reality software, while ARBiN is the patented combination of software and real-time navigation in one and the same box. ORG.NO:992104678 Website: https://www.augmenti.no/ Bitreactive AS Founded:2011 Sector:ICT Bitreactive provides a unique software stack and services focused on developing industrial Internet of things (IoT) solutions. The company helps with connecting devices to the internet, select hardware for data collection and manage data flow. Its solutions can be applied in in homes and in industrial settings. Bitreactive has developed the BALT Sleep Monitor, a sleep monitoring application based on a ballistocardiographic sensor and our Reactive Gateway. The device follows the sleep of a patient and supports live monitoring of bed-occupancy, movement-intensity, and even heart-rate. Each morning it summarizes the collected data of the night into an intuitive status-update which makes it easy for the healthcare personnel to prepare adequately for the coming day. ORG.NO:997140672 Website: http://www.bitreactive.com/ APIM Therapeutics AS Founded:2009 Sector:BIOTECH APIM is a drug discovery company developing anti-cancer drugs based on a discovery by professor Marit Otterlei at NTNU. The company targets a novel therapeutic intervention point shown to be critical in the regulation of cellular responses to stress and in tumor evasion from therapy. ATX-101, our lead drug candidate is currently being tested in a phase I clinical study in advanced cancer patients. The company has a strong interest in the fields of multiple myeloma and bladder cancer (advanced and localized/superficial). By exploiting a novel therapeutic target, our vision is to develop novel single agent & combinatorial cancer treatments with the potential to address serious unmet patient needs. ORG.NO:894298946 Website: http://www.apim-therapeutics.com/ HOME ABOUT FUNDS INVESTORS CONTACT CONTACT US: Email:post@televenture.no Telephone:(+47) 22779910 MAKING VENTURE HAPPEN CONTACT FORM: Name Email * Phone No. Write your query here Send TELEVENTURE WEBSITE By SHUBHAM KHATRI